I am sure it's a done deal. But this should say it all:

“We are pleased with our discussions with Resverlogix and its entire team and believe in the recent Breakthrough Therapy Designation granted by the FDA; Apabetalone and its effect on cardiovascular, CKD, Alzheimer’s and COVID-19 as well as its contribution to the future of mankind,” said Sheikh Abdulgader."

Don is stretching out every little bit of good news as much as possible to keep the stock buoyant if you get the drift as we inch towards the partnership finish line.

Koo